Question: According to research published in 1999 by Alan Green and the Center for Public Integrity (CPI), loopholes in the ESA are commonly exploited in the exotic pet trade. Although the legislation prohibits interstate and foreign transactions for list species, no provisions are made for in-state commerce, allowing these animals to be sold to roadside zoos and private collectors. Additionally, the ESA allows listed species to be shipped across state lines as long as they are not sold. According to Green and the CPI, this allows dealers to "donate" listed species through supposed "breeding loans" to anyone, and in return they can legally receive a reciprocal monetary "donation" from the receiving party. Furthermore, an interview with an endangered species specialist at the US Fish and Wildlife Service revealed that the agency does not have sufficient staff to perform undercover investigations, which would catch these false "donations" and other mislabeled transactions.
Is there an answer to this question: What is one particular industry that exploits Endangered Species Act loopholes?

Answer: exotic pet trade


Question: Incandescent light bulbs consist of an air-tight glass enclosure (the envelope, or bulb) with a filament of tungsten wire inside the bulb, through which an electric current is passed. Contact wires and a base with two (or more) conductors provide electrical connections to the filament. Incandescent light bulbs usually contain a stem or glass mount anchored to the bulb's base that allows the electrical contacts to run through the envelope without air or gas leaks. Small wires embedded in the stem in turn support the filament and its lead wires.
Is there an answer to this question: What does not support the filament and its lead wires?

Answer: unanswerable


Question: As a result of the magnitude 7.9 earthquake and the many strong aftershocks, many rivers became blocked by large landslides, which resulted in the formation of "quake lakes" behind the blockages; these massive amounts of water were pooling up at a very high rate behind the natural landslide dams and it was feared that the blockages would eventually crumble under the weight of the ever-increasing water mass, potentially endangering the lives of millions of people living downstream. As of May 27, 2008, 34 lakes had formed due to earthquake debris blocking and damming rivers, and it was estimated that 28 of them were still of potential danger to the local people. Entire villages had to be evacuated because of the resultant flooding.
Is there an answer to this question: How many of the lakes were a danger to people?

Answer: 28


Question: Drug discovery and development is very expensive; of all compounds investigated for use in humans only a small fraction are eventually approved in most nations by government appointed medical institutions or boards, who have to approve new drugs before they can be marketed in those countries. In 2010 18 NMEs (New Molecular Entities) were approved and three biologics by the FDA, or 21 in total, which is down from 26 in 2009 and 24 in 2008. On the other hand, there were only 18 approvals in total in 2007 and 22 back in 2006. Since 2001, the Center for Drug Evaluation and Research has averaged 22.9 approvals a year. This approval comes only after heavy investment in pre-clinical development and clinical trials, as well as a commitment to ongoing safety monitoring. Drugs which fail part-way through this process often incur large costs, while generating no revenue in return. If the cost of these failed drugs is taken into account, the cost of developing a successful new drug (new chemical entity, or NCE), has been estimated at about 1.3 billion USD(not including marketing expenses). Professors Light and Lexchin reported in 2012, however, that the rate of approval for new drugs has been a relatively stable average rate of 15 to 25 for decades.
Is there an answer to this question: How much does it cost to develop a new drug?

Answer:
about 1.3 billion